Study after study finds exercise and physical activity having numerous health benefits, such as a lower risk of developing diabetes. But research is also finding that exercise helps keep cancer in remission.
But why isn't that more widely known? Why aren't cancer patients told that exercise lowers the risk of cancer returning? Why isn't this part of their treatment? After all, a goal of cancer treatment is remission and not have the cancer return. The exercise evidence is so strong that it can be called a "therapeutic intervention".
One thing everyone is realizing is that you can't just tell persons undergoing cancer treatment to "exercise more", they need support - such as trainers, personalized exercises, supervised sessions, as well as financial and insurance overage for the costs involved.
The evidence from a large 2025 study that exercise helps lower the risk of cancer returning was compelling. In the study, after surgery and chemotherapy for colon cancer the 8-year overall survival rate was 90.3% in the exercise program group and 83.2% in the group that only received health education. Guidelines now recommend that colon cancer patients achieve at least 150 minutes of moderate to rigorous exercise per week.
Exercise appears to have the same benefits in breast cancer.
Excerpts from NY Times: It Can Keep Cancer in Remission. Why Is No One Talking About It?
Lee Colker powered on an iPad in the basement of his Pittsburgh home and logged into a virtual exercise session with Olivia Masten, a trainer who specializes in working with cancer patients.
Mr. Colker, 66, had been dealing with unpredictable fatigue and brain fog since beginning a clinical trial for metastatic kidney cancer this year. When staff at the University of Pittsburgh Medical Center told him an exercise program could improve his energy, he jumped at the opportunity. “That was a clincher for me,” he said.
The program is part of a growing effort around the country to help cancer patients exercise, as the benefits of doing so become increasingly clear.
Observational research has long suggested that exercise improves cancer survival, particularly for breast cancer patients. Last year, a landmark randomized controlled trial showed that colon cancer patients who participated in a structured exercise program with a trainer-coach over three years were less likely to see their cancers come back and had a better quality of life. Among those in the program, 90 percent were alive after eight years, compared with 83 percent in the control group.
A later study showed the program, which altogether cost $3,000 per person, also saved the health system money — “a home run,” said Dr. Scott Ramsey, a cancer researcher and health economist at the Fred Hutch Cancer Center in Washington State.
That combination of benefits is rare among cancer therapies: The new pancreatic cancer drug daraxonrasib, for example, costs $480,000 annually, has unpleasant side effects and, while it prolongs life by several months, does not increase overall long-term survival.
“If we had a drug with this magnitude of benefit, it would immediately become standard of care and funded” by insurance companies, said Dr. Christopher Booth, an oncologist and professor at Queen’s University in Kingston, Ontario, and the leader of the exercise trial.
While guidelines now recommend that oncologists help colon cancer patients achieve at least 150 minutes of moderate to rigorous exercise per week, many patients need support in the form of a structured program, with a trainer and supervised sessions, to get to that level and stick with it. But there’s not yet an insurance pathway to pay for such programs — a major barrier to rolling them out more widely.
"You can tell patients that if you do this, you may survive longer,” Dr. Ramsey said. But unfortunately, he added, “we just don’t have the infrastructure.”
Current programs are largely limited to major cancer centers and dependent on philanthropy or individual out-of-pocket payments to cover costs, leaving poorer patients and those who live far from these centers without access.
Dr. Schmitz is the founding director of Moving Through Cancer, the program in which Mr. Colker is participating. It is tailored to each patient: Some need more support, while others “are well enough to go out and play some pickleball,” she said.
Because of the success in people like Ms. Barker, U.P.M.C. has decided to offer the program through its employee health plan for breast cancer patients beginning next year.
The health system will be the first in the country to offer insurance coverage for exercise oncology, Dr. Schmitz said. She and her colleagues argued for it based on randomized trials that showed it saved costs by reducing hospitalizations, emergency room trips and unplanned office visits.